{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:25:13Z","timestamp":1792650313662,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cell.2020.06.044","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T02:41:59Z","timestamp":1594608119000},"page":"843-854.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":309,"title":["Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients"],"prefix":"10.1016","volume":"182","author":[{"given":"Christoph","family":"Kreer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Zehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timm","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem S.","family":"Ercanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Gieselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Halwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Korenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schommers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Vanshylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Di Cristanziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Janicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhild","family":"Brinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Ashurov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Kr\u00e4hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kupke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Cohen-Dvashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Mathis","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.G.T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Wendtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Diskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gruell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2020.06.044_bib1","article-title":"Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients","author":"Andreano","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2020.06.044_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","author":"Baum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib3","article-title":"Presence of SARS-CoV-2 reactive T\u00a0cells in COVID-19 patients and healthy donors","author":"Braun","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.cell.2020.06.044_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.chom.2020.04.022","article-title":"Rational Vaccine Design in the Time of COVID-19","volume":"27","author":"Burton","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2020.06.044_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells","author":"Cao","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.cell.2020.06.044_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib8","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","article-title":"Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection","volume":"177","author":"Davis","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cell.2020.06.044_bib10","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2020.06.044_bib11","article-title":"raxmlGUI 2.0 beta: a graphical interface and toolkit for phylogenetic analyses using RAxML","author":"Edler","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2020.06.044_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41591-019-0602-4","article-title":"Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV","volume":"25","author":"Ehrhardt","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.06.044_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-2836(84)90309-7","article-title":"Analysis of membrane and surface protein sequences with the hydrophobic moment plot","volume":"179","author":"Eisenberg","year":"1984","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.cell.2020.06.044_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.aac6300","article-title":"PUBLIC HEALTH. Toward an HIV vaccine: A scientific journey","volume":"349","author":"Fauci","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T\u00a0cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib19","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2020.06.044_bib20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.cell.2016.05.024","article-title":"Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity","volume":"165","author":"Huang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2020.06.044_bib22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.06.044_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1241144","article-title":"Antibodies in HIV-1 vaccine development and therapy","volume":"341","author":"Klein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib74","first-page":"827","article-title":"Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial","volume":"20","author":"Koch","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.cell.2020.06.044_bib26","doi-asserted-by":"crossref","first-page":"1232910","DOI":"10.1126\/science.1232910","article-title":"Accelerating next-generation vaccine development for global disease prevention","volume":"340","author":"Koff","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/biot.201400821","article-title":"Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines","volume":"10","author":"Kowarz","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.cell.2020.06.044_bib28","doi-asserted-by":"crossref","first-page":"112752","DOI":"10.1016\/j.jim.2020.112752","article-title":"openPrimeR for multiplex amplification of highly diverse templates","volume":"480","author":"Kreer","year":"2020","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cell.2020.06.044_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/vaccines8010013","article-title":"Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies","volume":"8","author":"Kreer","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cell.2020.06.044_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm.2071","article-title":"Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming","volume":"16","author":"Kwakkenbos","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.06.044_bib31","article-title":"Potent neutralization of SARS-CoV-2 in\u00a0vitro and in an animal model by a human monoclonal antibody","author":"Li","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2020.06.044_bib32","article-title":"Potent Neutralizing Monoclonal Antibodies Directed to Multiple Epitopes on the SARS-CoV-2 Spike","author":"Liu","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2020.06.044_bib33","article-title":"Neutralizing Antibodies Isolated by a site-directed Screening have Potent Protection on SARS-CoV-2 Infection","author":"Liu","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2020.06.044_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.06.044_bib35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.06.044_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-030409-101256","article-title":"The role of antibodies in HIV vaccines","volume":"28","author":"Mascola","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cell.2020.06.044_bib37","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2020.06.044_bib38","series-title":"{nlme}: Linear and Nonlinear Mixed Effects Models. R package version 3.1-148","author":"Pinheiro","year":"2020"},{"key":"10.1016\/j.cell.2020.06.044_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","author":"Pinto","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.cell.2020.06.044_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals","author":"Robbiani","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.cell.2020.06.044_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review","author":"Sanders","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.cell.2020.06.044_bib43","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib44","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2020.01.010","article-title":"Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody","volume":"180","author":"Schommers","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib46","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.cell.2020.05.041","article-title":"Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19","volume":"181","author":"Sempowski","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.06.001","article-title":"Analysis of a SARS-CoV-2 infected individual reveals development of potent neutralizing antibodies to distinct epitopes with limited somatic mutation","author":"Seydoux","year":"2020","journal-title":"Immunity."},{"key":"10.1016\/j.cell.2020.06.044_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor binding site of SARS-CoV-2","author":"Shi","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.cell.2020.06.044_bib49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.cell.2020.06.044_bib50","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.cell.2020.06.044_bib51","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/bioinformatics\/btu033","article-title":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies","volume":"30","author":"Stamatakis","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2020.06.044_bib52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cell.2020.06.044_bib53","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/bioinformatics\/btu138","article-title":"pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires","volume":"30","author":"Vander Heiden","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cell.2020.06.044_bib54","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/nprot.2016.102","article-title":"Sequencing and cloning of antigen-specific antibodies from mouse memory B cells","volume":"11","author":"von Boehmer","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cell.2020.06.044_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nri.2017.148","article-title":"Passive immunotherapy of viral infections: \u2018super-antibodies\u2019 enter the fray","volume":"18","author":"Walker","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2020.06.044_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib58","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/s41467-020-16256-y","article-title":"A human monoclonal antibody blocking SARS-CoV-2 infection","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2020.06.044_bib59","article-title":"SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease","author":"Wang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2020.06.044_bib60","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1073\/pnas.1921388117","article-title":"Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine","volume":"117","author":"Wec","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2020.06.044_bib61","first-page":"eabc7424","article-title":"Broad neutralization of SARS-related viruses by human monoclonal antibodies","author":"Wec","year":"2020","journal-title":"Science,"},{"key":"10.1016\/j.cell.2020.06.044_bib62","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","article-title":"Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies","volume":"181","author":"Wrapp","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.044_bib63","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib64","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","author":"Wu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.044_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2020.06.044_bib67","article-title":"Isolation of and Characterization of Neutralizing Antibodies to Covid-19 from a Large Human Na\u00efve scFv Phage Display Library","author":"Yuan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2020.06.044_bib68","article-title":"Blocking antibodies against SARS-CoV-2 RBD isolated from a phage display antibody library using a competitive biopanning strategy","author":"Zeng","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2020.06.044_bib69","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.20120150","article-title":"Germinal center B cells govern their own fate via antibody feedback","volume":"210","author":"Zhang","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2020.06.044_bib70","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.06.044_bib71","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2020.06.044_bib72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/COH.0000000000000551","article-title":"Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV","volume":"14","author":"Zolla-Pazner","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.cell.2020.06.044_bib73","article-title":"Potently\u00a0neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals","author":"Zost","year":"2020","journal-title":"bioRxiv"}],"updated-by":[{"DOI":"10.1016\/j.cell.2020.08.046","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000}}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867420308217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867420308217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:46:22Z","timestamp":1758800782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867420308217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0092867420308217"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2020.06.044","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.12.146290","asserted-by":"object"}]},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2020.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}